teplizumab January 19, 2018 teplizumab Trade Name Orphan Indication Recent-onset Type I diabetes USA Market Approval USA USA Designation Date 2006-09-29 00:00:00 Sponsor MacroGenics, Inc.;9704 Medical Center Drive;Rockville, Maryland, 20850
